APA
MESO

American Portfolios Advisors’s Mesoblast MESO Stock Holding History

American Portfolios Advisors’s Portfolio MESO Stock Details MESO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-500
Closed -$4.12K – 2637
2018
Q4 		$4.12K Buy
+500
New +$5.73K ﹤0.01% 1940

Other funds holding MESO

PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PCM
Princeton Capital Management Red Bank, New Jersey $367M AUM 45.24% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
OWD
Osborn Williams & Donohoe Cincinnati, Ohio $762M AUM 2.74% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

American Portfolios Advisors's MESO Position: Q1 2019 in Review

American Portfolios Advisors sold out of Mesoblast (MESO) in Q1 2019, closing a stake of 500 shares — an estimated $4.12K sold.

American Portfolios Advisors first reported a position in MESO in Q4 2018 and held it in 1 quarter. The position peaked at $4.12K in Q4 2018. 23 funds tracked by Wall St. Rank hold MESO as of Q1 2019.

  • American Portfolios Advisors reported no remaining Mesoblast position as of Q1 2019 after selling out during the quarter.
  • American Portfolios Advisors sold 500 Mesoblast shares in Q1 2019, an estimated $4.12K.
  • American Portfolios Advisors first reported a position in Mesoblast in Q4 2018 and held it in 1 quarter.
  • American Portfolios Advisors's Mesoblast position peaked at $4.12K in Q4 2018.
  • 23 funds tracked by Wall St. Rank held Mesoblast as of Q1 2019.

Based on American Portfolios Advisors's 13F filing for Q1 2019, filed 24 Mar 2023.